111 Inc
NASDAQ:YI
111 Inc
EPS (Diluted)
111 Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
EPS (Diluted)
-¥2
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
EPS (Diluted)
¥1
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
EPS (Diluted)
¥2
|
CAGR 3-Years
5%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
EPS (Diluted)
¥1
|
CAGR 3-Years
8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's EPS (Diluted)?
EPS (Diluted)
-2.3
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's EPS (Diluted) amounts to -2.3 CNY.
What is 111 Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
0%
Over the last year, the EPS (Diluted) growth was 7%. The average annual EPS (Diluted) growth rates for 111 Inc have been 6% over the past three years .